Skip to main content

DEA Extends Telemedicine Buprenorphine Rules Through 2026

A final rule now permanently allows buprenorphine via telehealth for up to 6 months without an in-person visit.

ByThe Rize NewsroomMay 8, 20261 min read

Body: [News-style article: what the rule changes, what the 6-month window means in practice, why the field had been bracing for a cliff, what clinicians and patients should know, caveats on state-by-state variation, how it affects telehealth-first programs like Bicycle Health and Ophelia. 800 words.]

Filed Under

DEAMAT — BuprenorphineFederalPolicy

Continue reading

More from this section